ZIVO BIOSCIENCE, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)

ZIVO

Item 5.07. Submission of Matters to a Vote of Security Holders.

At the annual meeting (the "Annual Meeting") of stockholders of Zivo Bioscience, Inc. (the "Company") on October 12, 2021, stockholders (i) elected five directors to the Company's Board of Directors (the "Board") to serve a one-year term until the 2022 annual meeting of stockholders, (ii) ratified the appointment of Wolinetz, Lafazan & Company, P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021, (iii) approved the Company's the adoption of the Zivo Bioscience, Inc. 2021 Equity Incentive Plan, and (iv) approved (on an advisory basis) the compensation of the Company's named executive officers. Proposals are described in detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on September 13, 2021, as supplemented on September 22, 2021.

A total of 5,624,833 shares of the Company's common stock were present at the meeting in person or by proxy, which represents approximately 60.6% of the shares of common stock outstanding as of the record date for the Annual Meeting.

The results of the voting are shown below:

Proposal 1-Election of Directors

Proposal 4-Approval (on an advisory basis) of the compensation of the Company's named executive officers

© Edgar Online, source Glimpses